Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 120, Issue 3, 1998, Pages 517-525

  Guyard Dangremont, Valérie ^a   Desrumaux, Catherine ^b   Gambert, Philippe ^b   Lallemant, Christian ^b   Lagrost, Laurent ^b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b INSERM   (France)

^c HÔPITAL DU BOCAGE   (France)

Author keywords

Animal; Atherosclerosis; Cholesteryl ester transfer protein; Phospholipid transfer protein; Plasma

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; PHOSPHOLIPID TRANSFER PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; ATHEROGENESIS; CATTLE; CHICKEN; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOG; DUCK; HORSE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; NORMAL HUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RABBIT; RAT; SHEEP; SPECIES DIFFERENCE; TROUT; VERTEBRATE;

EID: 0031839452     PISSN: 03050491     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-0491(98)10038-X     Document Type: Article

References (49)

1. Armstrong ML, Heistad DD. Animal models of atherosclerosis. Atherosclerosis 1990;85:15-23.
2. Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J Clin Invest 1991;87:1259-65.
3. Ballantyne FC, Clark RS, Simpson HS, Ballantyne D. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Metabolism 1982;31:433-7.
4. Chapman MJ. Comparative analysis of mammalian plasma lipoproteins. Methods Enzymol 1986;128:70-143.
5. Cheung MC, Brown BG, Wolf A, Albers JJ. Altered particle size distribution of apolipoprotein A-I containing lipoproteins in subjects with coronary artery disease. J Lipid Res 1991;32:383-94.
6. Cheung MC, Wolfbauer G, Albers JJ. Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. Biochim Biophys Acta 1996;1303:103-10.
7. 14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating factor using a rapid transfer assay. Biochim Biophys Acta 1982;712:444-52.
8. Day JR, Albers JJ, Lofton-Day CE, Gilbert TL, Ching AFT, Grant FJ, O'Hara PJ, Marcovina SM, Adolphson JL. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem 1994;269:9388-91.
9. Drayna D, Jarnagin AS, McLean J, Henzel W, Kohr W, Fielding C, Lawn R. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 1987;327:632-4.
10. Franceschini G, Chiesa G, Sirtori CR. Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients. Eur J Clin Invest 1991;21:384-8.
11. Francone OL, Royer L, Haghpassand M. Increased pre-beta HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apo A-I) transgenes. J Lipid Res 1996;37:1268-77.
12. Guyard-Dangremont V, Lagrost L, Gambert P, Lallemant C. Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP). Clin Chim Acta 1994;231:147-60.
13. Ha YC, Barter PJ. Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp Biochem Physiol 1982;71B:265-9.
14. Hailman E, Albers JJ, Wolfbauer G, Tu A-Y, Wright SD. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J Biol Chem 1996;271:12172-8.
15. Hayek T, Azrolan N, Verdery RB, Walsh A, Chajek-Shaul T, Agellon LB, Tall AR, Breslow JL. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. J Clin Invest 1993;92:1143-52.
16. Hirano KI, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, Arai T, Yanagi K, Takami S, Menju M, Ishigami M, Yoshida Y, Kameda-Takemura K, Hayashi K, Matsuzawa Y. Atherosclerotic disease in marked hyperalphalipoproteinemia: combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol 1995;15:1849-1856.
17. Hirano KI, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, Ishigami M, Sakai N, Kameda-Takemura K, Matsuzawa Y. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscer Thromb Vasc Biol 1997;17:1053-9.
18. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, van Tol A, Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993;268:4032-6.
19. Jiang X-C, Moulin P, Quinet E, Goldberg IJ, Yacoub LK, Agellon LB, Compton D, Schnitzer-Polokoff R, Tall AR. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem 1991;266:4631-9.
20. Jiang X-C, Bruce C. Regulation of murine plasma phospholipid transfer protein activity and mRNA levels by lipopolysaccharide and high cholesterol diet. J Biol Chem 1995;270:17133-8.
21. Jiang X-C, Bruce C, Cocke T, Wang S, Boguski M, Tall AR. Point mutagenesis of positively charged amino acids of cholesteryl ester transfer protein: conserved residues within the lipid transfer/lipopolysaccharide binding protein gene family essential for function. Biochemistry 1995;34:7258-63.
22. Jiang X-C, Francone OL, Bruce C, Milne R, Mar J, Walsh A, Breslow JL, Tall AR. Increased preβ-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest 1996;98:2373-80.
23. Johansson J, Carlson LA, Landou C, Hamsten A. High density lipoproteins and coronary atherosclerosis: a strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991;11:174-82.
24. Kostner GM, Oettl K, Jauhiainen M, Ehnholm C, Esterbauer H, Dieplinger H. Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem J 1995;305:659-67.
25. Lagrost L. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1994;1215:209-36.
26. Lagrost L. The role of cholesteryl ester transfer protein and phospholipid transfer protein in the remodeling of plasma high-density lipoproteins. Trends Cardiovasc Med 1997;7:27-33.
27. Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V, Lallemant C, Gambert P. Influence of cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler Thromb 1993;13:815-25.
28. Lagrost L, Athias A, Gambert P, Lallemant C. Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein. J Lipid Res 1994;35:825-35.
29. Lagrost L, Perségol L, Lallemant C, Gambert P. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins A-I and A-II. J Biol Chem 1994;269:3189-97.
30. Lagrost L, Athias A, Herbeth B, Guyard-Dangremont V, Arthur Y, Paille F, Gambert P, Lallemant C. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients. J Biol Chem 1996;271:19058-65.
31. Liu M, Bagdade JD, Subbaiah PV. Specificity of lecithin:cholesterol acyltransferase and atherogenic risk: comparative studies on the plasma composition and in vitro synthesis of cholesteryl esters in 14 vertebrate species. J Lipid Res 1995;36:1813-24.
32. McPherson R, Hogue M, Milne RW, Tall AR, Marcel YL. Increase in plasma cholesteryl ester transfer protein during probucol treatment: relation to changes in high density lipoprotein composition. Arterioscler Thromb 1991;11:476-81.
33. McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, Marcel YL. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 1991;11:797-804.
34. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993;364:73-5.
35. Melchior GW, Castle CK, Murray RW, Blake WL, Dinh DM, Marotti KR. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice: insights into the mechanisms responsible for low plasma high density lipoprotein levels. J Biol Chem 1994;269:8044-51.
36. Miller NE, Hammett F, Saltissi S, Rao S, van Zeller H, Coltart J, Lewis B. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J 1981;282:1741-4.
37. Nagashima M, McLean JW, Lawn RM. Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein. J Lipid Res 1988;29:1643-9.
38. Nishida HI, Nishida T. Phospholipid transfer protein mediates transfer of not only phosphatidylcholine but also cholesterol from phosphatidylcholine-cholesterol vesicles to high density lipoproteins. J Biol Chem 1997;272:6959-64.
39. Pape ME, Rehberg EF, Marotti KR, Melchior G. Molecular cloning, sequence, and expression of cynomolgus monkey cholesteryl ester transfer protein: inverse correlation between hepatic cholesteryl ester transfer protein mRNA levels and plasma high density lipoprotein levels. Arterioscler Thromb 1991;11:1759-71.
40. Quinet E, Tall AR, Ramakrishnan R, Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest 1991;87:1559-66.
41. Speijer H, Groener JEM, van Ramshorst E, van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 1991;90:159-68.
42. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993;34:1255-74.
43. Tall AR. Plasma lipid transfer proteins. Annu Rev Biochem 1995;64:235-57.
44. Tall AR, Granot E, Brocia R, Tabas I, Hesler C, Williams K, Denke M. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest 1987;79:1217-25.
45. Tollefson JH, Ravnik S, Albers JJ. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res 1988;29:1593-602.
46. Tu A-Y, Nishida HI, Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 1993;268:23098-105.
47. von Eckardstein A, Jauhiainen M, Huang Y, Metso J, Langer C, Pussinen P, Wu S, Ehnholm C, Assmann G. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre-beta1-HDL. Biochim Biophys Acta 1996;1301:255-62.
48. Watson TDG, Packard CJ, Shepherd J. Plasma lipid transport in the horse (Equus caballus). Comp Biochem Physiol 1993;106B:27-34.
49. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, Tall AR. Increased coronary heart disease in Japanese-American men with mutations in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996;97: 2917-23.